NTI Recorded Session NTI25221

GLP-1 Agonists: The Not-So-New VIPs in Town

Author(s): Katherine C Hammond, DNP, FNP-C, APRN, CEN

Contact Hours 1.00

CERP A 1.00

Pharmacology Hours 1.00

Expires Dec 31, 2027

Topics: Pharmacology, Medication Management

Population: Adult

Role: Educator, APRN, Staff

Start Activity
Fees
Member: Free
NonMember: $10.00
Get CE

Added to Collection

Activity Summary

There is a substantial history of GLP-1 agonists as antidiabetic medications, but in the last 3 years they have become extremely popular and controversial in their use as weight-loss agents. While for the most part GLP-1 agonists are very safe, there are a few specific complications seen with their use. However, those complications are not nearly as common as the media has led the public to believe. In this presentation we discuss the mechanism of action of GLP-1 agonists, why they are so effective for weight loss and diabetes and the side effects and complications for which to monitor. Additionally, we discuss important elements of patient education, newer trends in off-label use, potential novel uses for GLP-1 agonists and the safety concerns with the use of compounding pharmacies. During the last part of the presentation, case studies are utilized to review the foundational knowledge acute and critical care nurses need to know to safely care for their patients taking GLP-1 agonist medications. Pharmacology content = 100%

Objectives

  • Describe the pharmacology of GLP-1 agonist medications.
  • Identify common side effects and truly adverse effects of GLP-1 agonist medications.
  • Summarize interactions, complications, and precautions of GLP-1 agonist medications in the critical care patients.

Continuing Education Disclosure Statement

Criteria for Awarding Contact Hours

Learners must complete the entire activity and the associated evaluation AND read Implicit Bias impacts patient outcomes. No partial credit will be awarded.

Accreditation

American Association of Critical-Care Nurses is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
Provider approved by the California Board of Registered Nursing, Provider number CEP 1036, for {contactHours} contact hours.

Disclosures

The Nurse Planner has determined that no individuals with the ability to control content of this activity have relevant relationships with ineligible companies.

Activities with pharmacotherapeutic credit are to assist the APRN in fulfilling their education requirements for licensure and certification renewals.

Refund Policy

Continuing Education Activities are nonrefundable.